About Us

QPRN vision

For over 20 years, the vision of the QPRN is to be a leader in representing a wide range of research stakeholders in the search to understand the cellular and molecular basis of pain, to improve our assessment and treatment (pharmacological and non-pharmacological) of pain, to improve prevention efforts, as well as to ensure efficient and effective knowledge translation to adopt best practices in the multiple sectors of our healthcare system.

research network

We aim at achieving our goals through cohesive efforts between a group of 90 researchers associated to the four University Health Networks (Réseaux universitaires intégrés de santé; RUIS) of the province of Quebec: Université Laval, McGill University, Université de Montréal and Université de Sherbrooke, and to the Université du Québec network, Concordia University, Bishop University and TELUQ.
The network also benefits from collaborations with partners of choice as well as clinical experts.

Funding of the QPRN

The Fonds de recherche du Québec (FRQ) allow to :

• Financially support the Pain Network
• Stimulate cutting edge research on chronic pain
• Perfect the public and health care professional’s education on chronic pain
• Improve our background knowledge on persistent pain
• Contribute to enhancing physicians judgement for diagnosing and treating persistent pain

Committees

QPRN Management committee

QPRN direction committee

The Management Committee of the network is composed of :

• Management Committee

• A representative of the Quebec Chronic Pain Association (AQDC)

Pierre Genest

• A representative of the Quebec Pain Society (SQD)

Philippe De Grandpré

• A representative of the Quebec Network of Junior Pain Investigators (QNJPI)

Maxime Kusik
Karen Ghoussoub

• A representative from each university

Philippe Sarret (Université de Sherbrooke)
Pierre Rainville (Université de Montréal)
Gilles Lavigne (CR-CHUM)
Yves de Koninck (Université Laval)
Reza Sharif Naeini (McGill University)

QPRN scientific committee

The Scientific Committee of the network is composed of :

• The Management Committee

• The directors of the Multidisciplinary Consortiums

Quebec Consortium on Treatment Efficacy and Safety: Éric Troncy, (Université de Montréal), Mélanie Bérubé, (Université Laval) and Laurent Dupuis, patient partner
Quebec Consortium on Eco-Bio-Psycho-Social Therapies and Approaches: Reza Sharif, (McGill University), Caroline Arbour, (Université de Montréal) and Sabrina Paquet, patient partner
Quebec Consortium on Pain Prevention and Sustainable Health for All: Estelle Carde, (Université de Montréal) and Amy Doucet, patient partner
Quebec Consortium on Continuum and Pain Care Trajectories: Gabrielle Pagé, (Université de Montréal), Marc-André Blanchette, (Université du Québec à Trois-Rivières) and Lesley Norris-Singer, patient partner
Quebec Consortium on Veteran’s Health: Timothy Wideman, (McGill University)

• The directors of the Technical Platforms

https://qprn.ca/fr/investigator/carolina-beraldo-meloto/Technical platform on molecular tools and cellular imaging : Marie-Ève Paquet (Université Laval)
Technical platform on preclinical systems monitoring : Jeffrey Mogil (McGill University)
Technical platform on brain imaging : Pierre Rainville (Université de Montréal) and Mathieu Roy (McGill University)
Technical platform on genetics and genomics analysis : Audrey Grant and Carol Meloto (McGill University)